ARC101 in Advanced Solid Tumors

To join this study, you would need to have certain advanced solid cancers, such as ovarian, testicular, or other similar cancers that show a specific marker called Claudin 6. Doctors will need to be able to measure or assess your cancer. You should also generally be in good health for someone with cancer, meaning you can mostly look after yourself and are able to move around without too much difficulty, and your body's main organs (like your liver and kidneys) are working well.

There are also reasons why you might not be able to join. For example, if your cancer has spread to your brain or spinal cord, or if you've recently been diagnosed with another type of cancer that isn't the one being studied. If you have a lot of fluid build-up in your tummy (called ascites) that isn't controlled, or if you're still experiencing bad side effects from previous cancer treatments, you might not be eligible.

Other reasons for not being able to take part include serious lung problems, certain autoimmune diseases that flare up, or if you are pregnant, breastfeeding, or planning to have children soon. The medical team will carefully review all these details with you to see if this study is suitable.

If you join this study, you'll receive the new medicine, ARC101. The study team will regularly check your health status through various tests, including blood tests, scans, and physical exams, to monitor how your body is responding to the medicine and to look for any side effects. You'll have scheduled clinic visits for these checks. The total duration of your participation will depend on how you respond to the treatment and what the study doctors decide is best for your care, but you would have regular follow-up for a period after your last dose. The exact number of visits, tests, and the overall length will be fully explained by the study team.